CQP(000950.SZ)

Last Updated 00:00:00
longbridge loading
Company Encyclopedia
View More
name
CQP
000950.SZ
C.Q. Pharmaceutical Holding Co., Ltd. engages in the wholesale and retail of medicines and medical devices. The company is involved in the pharmaceutical commerce, warehousing logistics, pharmaceutical industry, and research and development businesses.
346.11 B
000950.SZMarket value -Rank by Market Cap -/-

Financial Score

20/05/2026 Update
C
Health Care DistributorsIndustry
Industry Ranking10/23
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE3.73%C
    • Profit Margin0.53%C
    • Gross Margin6.85%E
  • Growth ScoreC
    • Revenue YoY0.88%C
    • Net Profit YoY41.58%B
    • Total Assets YoY0.43%C
    • Net Assets YoY0.44%C
  • Cash ScoreD
    • Cash Flow Margin-91.85%E
    • OCF YoY0.88%C
  • Operating ScoreA
    • Turnover1.2A
  • Debt ScoreE
    • Gearing Ratio75.66%E

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    A-share pharmaceutical commercial stocks continue to decline, with Shuyu Pingmin dropping over 18%. HRPC, DAJIAWEIKANG, INT'L GROUP, and Hezong Medicine Easy-To-Buy Pharmaceutical all fell more than 5%, while Huaren Health, CQP, and Kaikai Industry also followed suit

    Wallstreetcn·
    SZ
    000950
    -0.31%
    SZ
    301126
    -2.20%
    SH
    600829
    -2.16%
    Wallstreetcn·
    SZ
    000950
    -0.31%
    SZ
    301126
    -2.20%
    SH
    600829
    -2.16%

    CQP: As of the end of October, a total of RMB 80.9988 million has been spent to repurchase shares

    Zhitong·
    SZ
    000950
    -0.31%
    Zhitong·
    SZ
    000950
    -0.31%

    General Technology CQP signs strategic cooperation agreement with Johnson & Johnson Innovation Pharmaceuticals

    Zhitong·
    SZ
    000950
    -0.31%
    Zhitong·
    SZ
    000950
    -0.31%

    CQP: In the third quarter, the net profit attributable to the parent company was 102 million yuan, an increase of 87.94% year-on-year

    Zhitong·
    SZ
    000950
    -0.31%
    Zhitong·
    SZ
    000950
    -0.31%

    CQP: It is expected that the net profit for the first three quarters will increase by 22.51%-36.88% year-on-year

    Zhitong·
    SZ
    000950
    -0.31%
    Zhitong·
    SZ
    000950
    -0.31%
    © 2026 Longbridge｜Disclaimer